非高密度脂蛋白胆固醇预测急性缺血性卒中不良结局
基于中国国家卒中登记II的19 604例急性缺血性卒中患者,其中16 113例具备总胆固醇和高密度脂蛋白胆固醇数据,按非高密度脂蛋白胆固醇(non-HDL-C)五分位分组,采用Cox回归分析其与1年内结局的关联。结果显示,non-HDL-C最高五分位与1年内复发性缺血性卒中风险升高相关,最高和最低五分位均与1年内全因死亡风险升高相关,但与颅内出血无显著预测关系。
要点
- non-HDL-C最高五分位者1年内复发性缺血性卒中风险升高(aHR 1.46)。
- non-HDL-C最高和最低五分位均与1年内全因死亡风险升高相关。
- non-HDL-C对颅内出血无显著预测作用。
核心结论
- non-HDL-C可能是有资格的预测指标,用于预测急性缺血性卒中患者1年内复发性缺血性卒中和全因死亡。
研究设计与样本
- 基于中国国家卒中登记II,19 604例急性缺血性卒中患者中16 113例具备总胆固醇和HDL-C数据并纳入分析。
- 按non-HDL-C五分位将患者分为5组,采用Cox回归模型分析其与结局的关系。
主要发现
- 16 113例患者non-HDL-C中位数(四分位间距)为3.41(2.78–4.10)mmol/L。
- 校正混杂变量后,与第三五分位相比,non-HDL-C最高五分位与1年内复发性缺血性卒中风险升高相关(aHR 1.46 [95% CI 1.20–1.77])。
- 与第三五分位相比,non-HDL-C最低和最高五分位均与1年内全因死亡风险升高相关(aHR 1.22 [95% CI 1.01–1.47]和aHR 1.40 [95% CI 1.15–1.70])。
- non-HDL-C水平对颅内出血无显著预测作用。
临床怎么用
- 对急性缺血性卒中患者,可关注non-HDL-C水平以辅助识别1年内复发缺血性卒中和全因死亡高风险人群。
- non-HDL-C过低或过高均与1年内全因死亡风险升高相关,临床评估时需兼顾两端。
- non-HDL-C不宜用于预测颅内出血风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Non–high-density lipoprotein cholesterol (non–HDL-C) was significantly related to adverse outcomes in patients with cardiovascular disease. We aim to investigate the associations of non-HDL-C and adverse outcomes in acute ischemic stroke. METHODS: Among 19 604 patients with acute ischemic stroke admitted to the China National Stroke Registry II, 16 113 with both total cholesterol and HDL-C were analyzed. Patients were classified into 5 groups by quintiles of non-HDL-C. The outcomes included recurrent ischemic stroke, intracranial hemorrhage, and all-cause death within 1 year. The relationship of non-HDL-C with the risk of outcomes was analyzed by Cox regression models. RESULTS: Among the 16 113 patients, the median (interquartile range) of non-HDL-C was 3.41 (2.78–4.10) mmol/L. After adjustment for confounding variables, patients in the top quintile of non-HDL-C were associated with higher risk of recurrent ischemic stroke within 1 year (adjusted hazard ratio, 1.46 [95% CI, 1.20–1.77]), compared with those in the third quintile. Patients in the bottom and top quintile of non-HDL-C were associated with higher risk of all-cause death within 1 year (adjusted hazard ratio, 1.22 [95% CI, 1.01–1.47] and adjusted hazard ratio, 1.40 [95% CI, 1.15–1.70], respectively), compared with those in the third quintile. However, non-HDL-C levels were not significantly predictive in intracranial hemorrhage. CONCLUSIONS: Non-HDL-C may be a qualified predictor for recurrent ischemic stroke and all-cause death within 1 year in patients with acute ischemic stroke.
引用
- Wang G, Jing J, Wang A, et al. Non-High-Density Lipoprotein Cholesterol Predicts Adverse Outcomes in Acute Ischemic Stroke. Stroke. 2021. PMID: 34000828. doi:10.1161/STROKEAHA.120.030783
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。